Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.5M Buy
+96,000
New +$11.1M ﹤0.01% 3405
2024
Q3
Sell
-263,400
Closed -$32.6M 5285
2024
Q2
$32.6M Sell
263,400
-1,649,500
-86% -$212M ﹤0.01% 2692
2024
Q1
$252M Buy
+1,912,900
New +$236M 0.01% 1490
2023
Q3
Sell
-476,000
Closed -$54.9M 5509
2023
Q2
$54.9M Buy
+476,000
New +$54M ﹤0.01% 2423
2023
Q1
Sell
-280,000
Closed -$31.1M 5659
2022
Q4
$31.1M Buy
+280,000
New +$28.6M ﹤0.01% 2782
2021
Q1
Sell
-1,253,303
Closed -$97.8M 5322
2020
Q4
$97.8M Sell
1,253,303
-1,219,663
-49% -$93.3M ﹤0.01% 2096
2020
Q3
$196M Buy
+2,472,966
New +$194M 0.01% 1407
2014
Q4
Sell
-5,240
Closed -$296K 3185
2014
Q3
$296K Buy
5,240
+838
+19% +$47.1K ﹤0.01% 1432
2014
Q2
$243K Hold
4,402
﹤0.01% 1458
2014
Q1
$238K Buy
+4,402
New +$228K ﹤0.01% 1499

Other funds holding MRK

BlackRock's MRK Position: Q1 2026 in Review

BlackRock increased its Merck (MRK) stake by 3.1% in Q1 2026, buying an estimated $778M and bringing the position to 225,830,330 shares worth $27.2B. The position accounts for 0.47% of the portfolio, ranked #28.

BlackRock first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.3B in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • BlackRock held 225,830,330 shares of Merck worth $27.2B as of Q1 2026.
  • BlackRock bought 6,734,865 Merck shares in Q1 2026, an estimated $778M.
  • Merck made up 0.47% of BlackRock's portfolio in Q1 2026, its #28 holding.
  • BlackRock first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's Merck position peaked at $27.3B in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.